Bacteremia caused by the novel species Mycobacterium canariasense

Eur J Clin Microbiol Infect Dis. 2006 Jan;25(1):58-60. doi: 10.1007/s10096-005-0079-6.

Authors

M I Campos-Herrero¹, D García, A Figuerola, P Suárez, C Campo, M J García

Affiliation

¹ Servicio de Microbiología, Hospital Universitario de Gran Canaria Dr. Negrín, Barranco de la Ballena s/n, 35020, Las Palmas de Gran Canaria, Canary Islands, Spain. mcamnavl@gobiernodecanarias.org

PMID: 16391913
DOI: 10.1007/s10096-005-0079-6

No abstract available

MeSH terms

Adult
Amikacin / therapeutic use
Anti-Bacterial Agents / therapeutic use
Bacteremia / diagnosis
Bacteremia / microbiology*
Bacteremia / therapy
Catheterization, Central Venous / adverse effects
Catheters, Indwelling / microbiology*
Cefoxitin / therapeutic use
Device Removal
Female
Humans
Leukemia / complications
Lymphoma / complications
Male
Middle Aged
Multiple Myeloma / complications
Mycobacterium / classification
Mycobacterium / isolation & purification*
Mycobacterium Infections / diagnosis
Mycobacterium Infections / microbiology*
Mycobacterium Infections / therapy
Retrospective Studies

Substances

Anti-Bacterial Agents
Cefoxitin
Amikacin